Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
December 1, 2022
Rhythm Pharmaceuticals to Present at BofA Securities 2022 Virtual Biotech SMID Cap Conference
November 21, 2022
Rhythm Pharmaceuticals Announces ▼IMCIVREE® (setmelanotide) Granted Marketing Authorization in Great Britain for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
Upcoming Events
December 8, 2022 at 9:40 AM EST
BofA Securities 2022 Virtual Biotech SMID Cap Conference
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120